AR053987A1 - Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas. - Google Patents

Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas.

Info

Publication number
AR053987A1
AR053987A1 ARP050105106A ARP050105106A AR053987A1 AR 053987 A1 AR053987 A1 AR 053987A1 AR P050105106 A ARP050105106 A AR P050105106A AR P050105106 A ARP050105106 A AR P050105106A AR 053987 A1 AR053987 A1 AR 053987A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
halogen
pharmaceutical compositions
cycloalkyl
hydroxy
Prior art date
Application number
ARP050105106A
Other languages
English (en)
Inventor
Alexander Flohr
Roland Jakob-Roetne
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR053987A1 publication Critical patent/AR053987A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Proceso de obtencion y composiciones farmacéuticas que los comprenden. Reivindicacion 1: Compuestos de la formula general (1) en la que R es halogeno, alquilo inferior o trifluorometilo; R1 es H, alquilo inferior o alquilo inferior sustituido por halogeno o hidroxi o es alquenilo inferior, -(CH2)n-cicloalquilo, -(CH2)n-COR' o es bencilo opcionalmente sustituido por halogeno o R' es alcoxi inferior, hidroxi o amino; R2 es H, alquilo inferior, trifluorometilo o cicloalquilo; R3 es alquilo inferior o alquilo inferior sustituido por halogeno o es bencilo opcionalmente sustituido por dos átomos de halogeno o es -(CH2)n-cicloalquilo o -(CH2)n-piridinilo; X es -CH2-, -CH(R4)-, -C(alquilo inferior)2-, -C(halogeno)(alquilo inferior)- o - CH(R4)-O-; R4 es alquilo, alquilo inferior, alcoxi inferior, hidroxi o -CH2-2-[1,3]dioxalano-; n es 0, 1 o 2; a sales de adicion de ácido farmacéuticamente aceptables de los mismos.
ARP050105106A 2004-12-08 2005-12-07 Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas. AR053987A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106395 2004-12-08
EP05100816 2005-02-07

Publications (1)

Publication Number Publication Date
AR053987A1 true AR053987A1 (es) 2007-05-30

Family

ID=36293585

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105106A AR053987A1 (es) 2004-12-08 2005-12-07 Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas.

Country Status (23)

Country Link
US (1) US7211573B2 (es)
EP (1) EP1828151B1 (es)
JP (1) JP4979590B2 (es)
KR (1) KR100890678B1 (es)
CN (1) CN101072760B (es)
AR (1) AR053987A1 (es)
AT (1) ATE504580T1 (es)
AU (1) AU2005313582B8 (es)
BR (1) BRPI0518615A2 (es)
CA (1) CA2589196A1 (es)
DE (1) DE602005027388D1 (es)
DK (1) DK1828151T3 (es)
HK (1) HK1114840A1 (es)
IL (1) IL183293A0 (es)
MX (1) MX2007006504A (es)
NO (1) NO20072609L (es)
NZ (1) NZ555184A (es)
PL (1) PL1828151T3 (es)
PT (1) PT1828151E (es)
RU (1) RU2402538C2 (es)
TW (1) TWI349005B (es)
WO (1) WO2006061136A2 (es)
ZA (1) ZA200705018B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2663240A1 (en) 2006-09-20 2008-03-27 F. Hoffmann-La Roche Ag 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives
MX2009007864A (es) * 2007-02-02 2009-07-31 Hoffmann La Roche Derivados de 6-oxo-6,7-dihidro-5h-dibenzo[b,d]azepin-7-ilo.
AU2009203776A1 (en) * 2008-01-11 2009-07-16 F. Hoffmann-La Roche Ag Use of a gamma-secretase inhibitor for treating cancer
US8741889B2 (en) * 2008-01-11 2014-06-03 Hoffmann-La Roche Inc Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor
WO2016198366A1 (en) 2015-06-11 2016-12-15 F. Hoffmann-La Roche Ag Targeted notch pathway inhibitors
EP3700904B1 (en) 2017-10-24 2023-07-19 Bayer AG 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
US20220017456A1 (en) * 2018-11-07 2022-01-20 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
WO2020216773A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one compounds
CA3137611A1 (en) 2019-04-24 2020-10-29 Bayer Aktiengesellschaft 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
MA55751A (fr) 2019-04-24 2022-03-02 Bayer Ag Composés de 4h-pyrrolo[3,2-c]pyridin-4-one
CN112300019A (zh) * 2019-07-31 2021-02-02 华东师范大学 一种邻乙酰氨基苯丁酸类化合物的制备方法
CA3177214A1 (en) 2020-03-31 2021-10-07 Bayer Aktiengesellschaft 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer
AU2022234513A1 (en) 2021-03-09 2023-09-21 Basf Se Malonamides and their use as herbicides
CR20240097A (es) * 2021-08-25 2024-05-20 Basf Se Malonamidas herbicidas
WO2023031200A1 (en) * 2021-08-31 2023-03-09 Basf Se Herbicidal malonamides containing a condensed ring system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
AU4707999A (en) * 1998-06-22 2000-01-10 Elan Pharmaceuticals, Inc. Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
GB0012671D0 (en) 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
PL212708B1 (pl) * 2002-05-29 2012-11-30 Hoffmann La Roche Pochodne N-acyloaminobenzenu, sposób ich wytwarzania, lek zawierajacy te pochodne i zastosowanie pochodnych N-acyloaminobenzenu
TW200502221A (en) * 2002-10-03 2005-01-16 Astrazeneca Ab Novel lactams and uses thereof
BRPI0407262A (pt) 2003-02-04 2006-01-31 Hoffmann La Roche Derivados de malonamida como inibidores gama-secretase
US7060698B2 (en) 2003-05-19 2006-06-13 Hoffmann-La Roche Inc. Benzoxazepinone derivatives
EP1711470B1 (en) 2003-09-09 2009-04-15 F. Hoffmann-La Roche Ag Malonamide derivatives blocking the activtiy of gamma-secretase
KR100867035B1 (ko) 2003-10-06 2008-11-04 에프. 호프만-라 로슈 아게 감마-세크레타제 저해제로서 유용한 치환된다이벤조-아제핀 및 벤조-다이아제핀 유도체

Also Published As

Publication number Publication date
JP2008522994A (ja) 2008-07-03
MX2007006504A (es) 2007-06-22
NO20072609L (no) 2007-06-19
PL1828151T3 (pl) 2011-09-30
TW200626568A (en) 2006-08-01
EP1828151A2 (en) 2007-09-05
HK1114840A1 (en) 2008-11-14
US20060122168A1 (en) 2006-06-08
CN101072760A (zh) 2007-11-14
AU2005313582B2 (en) 2011-06-02
DE602005027388D1 (de) 2011-05-19
KR20070086979A (ko) 2007-08-27
EP1828151B1 (en) 2011-04-06
AU2005313582A8 (en) 2011-06-16
WO2006061136A3 (en) 2006-08-03
BRPI0518615A2 (pt) 2008-11-25
AU2005313582B8 (en) 2011-06-16
RU2402538C2 (ru) 2010-10-27
US7211573B2 (en) 2007-05-01
KR100890678B1 (ko) 2009-03-26
CA2589196A1 (en) 2006-06-15
ATE504580T1 (de) 2011-04-15
IL183293A0 (en) 2007-09-20
JP4979590B2 (ja) 2012-07-18
CN101072760B (zh) 2011-12-28
RU2007120211A (ru) 2009-01-20
NZ555184A (en) 2010-01-29
TWI349005B (en) 2011-09-21
DK1828151T3 (da) 2011-05-16
PT1828151E (pt) 2011-06-16
AU2005313582A1 (en) 2006-06-15
WO2006061136A2 (en) 2006-06-15
ZA200705018B (en) 2010-04-28

Similar Documents

Publication Publication Date Title
AR053987A1 (es) Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas.
DK1140745T3 (da) Colchinolderivater som vaskulært skadelige midler
RS50932B (sr) N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
ATE427932T1 (de) 11beta-hsd1-inhibitoren
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
EP1813270A4 (en) PROTEIN INHIBITORS OF THE HSP90 FAMILY
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
AR054102A1 (es) Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas
BRPI0409465A (pt) derivados de carboxamida como agentes antidiabéticos
EA200300071A1 (ru) Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина
BRPI0512086A (pt) composto e os sais farmacologicamente aceitáveis do mesmo, composição farmacêutica, e, processo para a preparação de compostos
DE60105610D1 (en) Pyrazinonderivate
NO961077L (no) Substituerte benzoltienylpiperaziner, deres anvendelse som medikamenter og fremgangsmåter for fremstilling
BRPI0408467A (pt) cromenonaindóis
BR0214488A (pt) Derivados de benzotiazol
BRPI0514077A (pt) derivados de benzilóxi como inibidores de maob
PA8545601A1 (es) Derivados de 4-aminopirimidina
RS20050954A (en) Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
CO5590900A2 (es) Fenilalquinos
ATE476420T1 (de) Alkaloidverbindungen und ihre verwendung als antimalariamittel
NO20020475D0 (no) 2-aminotetralinderivater for terapi av glaukom

Legal Events

Date Code Title Description
FB Suspension of granting procedure